Investors
Investors > As an investment
Revenio as an investment
Revenio is a global leader in ophthalmological devices and software solutions. We focus on eye care solutions; our objective is to improve the quality of clinical diagnostics with targeted product innovations and software solutions.
Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters as well as related software solutions. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).
We enable efficient diagnostics of eye diseases
We use Finnish technology to improve the quality of life of people around the world. Health care megatrends, such as aging populations and a global need for cost savings, support our growth targets.
Since 2016, Revenio has been taking market share with a CAGR of approximately 27% revenue growth rate compared to the market growth rate of approximately 4-6%. When eliminating the impact of the Centervue acquisition, the growth rate has been slightly above 13%. Revenio remains committed to continued improvement of its market share on all product lines with the aim of accelerating the organic growth. The company also continues to scan the market for acquisition opportunities to expand its product portfolio within the ophthalmic diagnostics and software solutions.
Approximately half of our share capital is owned by private investors and briskly traded. We always seek to remember our owners and have a history of good dividend payment performance.
Strategy add
The cornerstones of Revenio’s strategy are (published March 16, 2021):
Focus fully on the eye care market
Improve the quality of clinical diagnostics with targeted product innovations
Transform clinical care pathways with eye care focused software solutions
Continue to develop stronger distribution and build on iCare brand awareness and client experience
Continue strong profitable growth
Competitive advantages add
Knowledge and people
Knowledge of the industry and global markets
Distribution channels
World-class quality products and processes
Technology
Research and development
Steady cash flow from sensor sales
Utilizing IP-protected Finnish inventions
Brand
- Strong and respected iCare brand
Production
- Volume flexible production model
Financial position strong
Profitability and balance sheet
Shareholder value
Growth drivers add
Health care facing unprecedented global challenges
The global megatrends are providing us long term eye care market growth opportunities. In our view the demand for global eye care is increasing due to the aging and growing population, along with changing lifestyles. Comprehensive eye care delivery systems are becoming more important due to the increased system costs and resource shortages. Furthermore, the demand for telehealth and remote monitoring across markets is continuing to increase also due to the COVID-19 pandemic.
Key market trends on the eye care market are the following:
Population growth
Population aging
Inequality
Chronic diseases become more common
Infrastructures are incapable of treating the required numbers of patients
.jpg)
Revenio Group Oyj | Äyritie 22 | 01510 Vantaa